Article
Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
Proceedings of the National Academy of Sciences of the United States of America - 1 Feb 2022
Belsare Ketaki D, Wu Haifan, Mondal Dibyendu, Bond Annalise, Castillo Erika, Jin Jia, Jo Hyunil, Roush Addison E, Pilla Kala Bharath, Sali Andrej, Condello Carlo, DeGrado William F
Abstract excerpt
Triggering receptor expressed on myeloid cells 2 (TREM2) is a single-pass transmembrane receptor of the immunoglobulin superfamily that is secreted in a soluble (sTREM2) form. Mutations in TREM2 have been linked to increased risk of Alzheimer's disease (AD). A prominent neuropathological component of AD is deposition of the amyloid-β (Aβ) into plaques, particularly Aβ40 and Aβ42. While the membrane-bound form of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
